New multiplex PCR method and application
Hybrid primers in multiplex PCR minimize competition and enhance specificity by incorporating the sequence of another primer, enabling efficient and sensitive amplification of multiple nucleic acid sequences.
Patent Information
- Application Number
- FR2020000902
- Authority / Receiving Office
- FR · FR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-01-30
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2040-01-30
AI Technical Summary
Multiplex PCR methods face challenges with high concentrations of primers leading to competition and non-specific amplifications, resulting in poor detection sensitivity and efficiency.
The method employs hybrid primers where the 5' end of one primer includes the sequence of another primer, allowing for differential amplification and reduced concentrations of secondary primers, thereby minimizing competition and enhancing specificity.
This approach achieves specific and efficient amplification of multiple nucleic acid sequences, favoring target nucleic acids for faster detection and analysis, while maintaining sensitivity and reducing non-specific amplifications.
Smart Images

Figure 00000020_0000 
Figure 00000020_0001 
Figure 00000021_0000
Abstract
Description
Title of the invention: New multiplex PCR method and use
[0001] The invention relates to the field of detection and amplification of a nucleic acid of interest, in particular in infectious diagnosis. The invention thus relates to a method for amplifying at least two distinct nucleic acid sequences present in a sample from a pair of primers 1 recognizing a 1st nucleic acid (A) and a pair of primers 2 recognizing a 2nd nucleic acid. In particular, the 1st oligonucleotide such as a sense oligonucleotide of the pair of primers 2 further comprises in 5' the sequence of the 1st oligonucleotide of the pair of primers 1, and the 2nd oligonucleotide of the pair of primers 2 further comprises in 5' the sequence of the 2nd oligonucleotide of the pair of primers 1. The invention also relates to the primers, a detection kit capable of implementing said method and its uses.
[0002] In recent years, infectious diagnosis has evolved significantly, particularly through the use of molecular biology methods such as genomic amplification or Polymerase Chain Reaction (PCR). PCR is increasingly replacing traditional serological and microbiological methods, such as bacterial culture or the ELISA test. The advantages of PCR are numerous; the test is rapid, sensitive and specific. Despite the cost still being quite high and therefore reserved for difficult analyses or certain analysis laboratories, the specificity and sensitivity of the diagnosis will eventually replace traditional analyses and be implemented as a first-line test.
[0003] PCR allows a very large quantity of samples to be analyzed in a short time thanks to multiplex technology. It is thus possible to amplify several nucleic acid targets from the same sample during a single PCR cycle. Multiplex PCR is a PCR method that allows several different nucleic acid sequences to be amplified simultaneously. It allows several separate PCR reactions to be carried out together in a single reaction. This method allows the nucleic acid in samples to be amplified using multiple primers and a polymerase in a thermocycler. Multiplex PCR is therefore particularly suitable for infectious diagnosis. During infectious diagnosis, different primers that target several bacteria, viruses or yeasts are placed in the presence of the target sample.
[0004] However, the primers need to be highly optimized so that all the primers can work at the same temperature during PCR, in particular to avoid the phenomenon of cross-reactions.
[0005] For example, multiplex PCR is capable of revealing at least one pathogen in community-acquired pneumonia in 77% of hospitalized patients, compared to 39% by culture (NJ Gadsby CD Russell MP McHugh Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis 2016). In diarrhea, it can detect up to three times more pathogens in stool than traditional methods (CR Stensvold HV Nielsen Comparison of microscopy and PCR for detection of intestinal parasites in Danish patients supports an incentive for molecular screening platforms. J Clin Microbiol 2012). Thus, a single test can highlight several infectious agents in less than two hours. Today, panels are already available to the clinician for meningitis, sexually transmitted infections, respiratory infections and infectious enterocolitis.
[0006] Multiplex PCR is also limited to the detection of a predefined quantity of pathogens, the primers of which are included in the panel. In order to extend the detection panel, the detection kit can include a very large number of primers, thus making it possible to detect a large quantity of microorganisms. The more one wishes to increase the number of pathogens detected, the more one will tend to increase the number of primers. Generally speaking, a pathogen is detected by a pair of primers.
[0007] However, a high concentration of different primers in a single test causes a contradictory deleterious effect. The appearance of a competition phenomenon between the primers resulting in inhibition of the primers and aspecific amplifications. Consequently, excessively high multiplexing results in very poor detection sensitivity.
[0008] It is also known from the work of I. Afonina et al. in 2007 (Primers with 5' flaps improve real-time PCR) that the addition in 5' of a sequence not complementary to the target of the primer improves the efficiency of PCR amplifications. However, these sequence additions do not resolve the problem of aspecific amplification or loss of sensitivity linked to the high concentrations of primers conventionally used during multiplex PCR.
[0009] The invention aims to resolve the problems and drawbacks of the prior art and in particular to eliminate or limit the presence of the phenomenon of competition between the primers when they are present in a single test in too large quantities as well as to eliminate or limit non-specific amplifications.
[0010] Thus, according to a first aspect, the invention relates to a method for amplifying at least two distinct nucleic acid sequences present in a sample from a pair of primers 1 capable of amplifying a 1st nucleic acid sequence (A) and a pair of primers 2 capable of amplifying a 2nd nucleic acid sequence. (B), said method comprising the following steps: a. bringing the sample into contact with the primer pair 1 capable of amplifying the first nucleic acid sequence (A) and the primer pair 2 capable of amplifying the second nucleic acid sequence (B), i. the primer pair 1 consisting of a 1st oligonucleotide and a 2nd oligonucleotide capable of amplifying a nucleic acid corresponding to the 1st sequence (A), ii. the primer pair 2 consisting of a 1st oligonucleotide and a 2nd oligonucleotide capable of amplifying a nucleic acid corresponding to the 2nd sequence (B), b. the addition of selected reagents and conditions enabling PCR amplification, and c. the amplification of the 1st and 2nd nucleic acid sequences, by carrying out a specific amplification reaction of the nucleic acid sequence (A) and the nucleic acid sequence (B) present in the sample, characterized in that the sequence of the 1st oligonucleotide of the primer pair 2 further comprises in 5' the sequence of the 1st oligonucleotide of the primer pair 1 and the sequence of the 2nd oligonucleotide of the primer pair 2 further comprises in 5' the sequence of the 2nd oligonucleotide of the primer pair 1.
[0011] Preferably, the concentration of primer pair 2 is less than or equal to that of primer pair 1.
[0012] The method according to the invention may also comprise a pair of primers 3, a pair of primers 4 etc., each comprising a 1st oligonucleotide whose sequence further comprises in 5' the sequence of the 1st oligonucleotide of the pair of primers 1 and a 2nd oligonucleotide whose sequence further comprises in 5' the sequence of the 2nd oligonucleotide of the pair of primers 1.
[0013] For example, the 1st oligonucleotide of the primer pair 1, 2, 3 or 4 can be a sense primer and the 2nd oligonucleotide of the primer pair 1, 2, 3 or 4 can be an antisense primer.
[0014] Preferably, the method according to the invention is a multiplex PCR and makes it possible to carry out differential quantitative amplifications. Said PCR according to the invention is also called Relay PCR in the remainder of the description.
[0015] The PCR according to the invention makes it possible in particular to detect and identify microorganisms such as bacteria, viruses, yeasts involved in infectious diseases.
[0016] According to a second aspect, the invention also relates to primers and kits comprising specific primers, a detection kit capable of implementing the method of the invention and its use for detecting microorganisms present during infectious diseases.
[0017] The invention is now described in detail with reference to the figures described below. The figures are only illustrative of certain embodiments of the invention and are not limiting. Figures
[0018] [fig. 1] represents the principle of the PCR Relay according to the invention.
[0019] [fig.2A] represents a standard Duplex PCR assay with a primer pair 1 targeting Staphyloccocus aureus and a primer pair 2 targeting Escherichia coli. In black: amplification curves targeting a specific gene of Escherichia coli. In gray: amplification curves targeting a specific gene of Staphyloccocus aureus.
[0020] [fig.2B] represents a Relay PCR assay according to the invention comprising a primer pair 1 targeting Staphyloccocus aureus and a primer pair 2 targeting Escherichia coli. The primer pair / primer pair 2 ratio is equal to 10:1. In black: amplification curves targeting a specific gene of Escherichia coli. In gray: amplification curves targeting a specific gene of Staphyloccocus aureus.
[0021] [fig.2C] represents a Relay PCR assay according to the invention comprising a primer pair 1 targeting Staphyloccocus aureus and a primer pair 2 targeting Escherichia coli. The primer pair / primer pair 2 ratio is equal to 1:1. In black: amplification curves targeting a specific gene of Escherichia coli. In gray: amplification curves targeting a specific gene of Staphyloccocus aureus.
[0022] [fig.3A] represents a standard Duplex PCR assay with primer pair 1 targeting Klebsiella pneumoniae and a primer pair 2 targeting Staphyloccocus aureus. In black: amplification curves targeting a specific gene of Klebsiella pneumoniae. In gray: amplification curves targeting a specific gene of Staphyloccocus aureus.
[0023] [fig.3B] represents a Relay PCR assay according to the invention comprising a primer pair 1 targeting Klebsiella pneumoniae and a primer pair 2 targeting Staphyloccocus aureus. The primer pair ratio Lprimer pair 2 is equal to 10:1. In black: amplification curves targeting a gene specific to Klebsiella pneumoniae. In gray: amplification curves targeting a gene specific to Staphyloccocus aureus.
[0024] [fig.3C] represents a Relay PCR assay according to the invention comprising a primer pair 1 targeting Klebsiella pneumoniae and a primer pair 2 targeting Staphyloccocus aureus. The primer pair / primer pair 2 ratio is equal to 1:1. In black: amplification curves targeting a gene specific to Klebsiella pneumoniae. In gray: amplification curves targeting a gene specific to Staphyloccocus aureus.
[0025] Definitions
[0026] For the purposes of the invention, the term "patient" means a subject that may be a human being or an animal, preferably a human being or a mammal. Preferably, the subject is a human patient, regardless of age or sex. Newborns, infants and children are also included.
[0027] For the purposes of the invention, diagnosis means a test which aims to detect and identify one or more pathology(ies), in particular the detection and identification of infectious diseases in order to be able to administer to the patient a treatment corresponding to the pathology.
[0028] For the purposes of the invention, the term “primer pair” or “oligonucleotide pair” means two oligonucleotides enabling a target sequence to be amplified in the context of a PCR.
[0029] For the purposes of the invention, the term “primer” or “oligonucleotide” or “primer” means a short segment of nucleic acids of a few dozen nucleotides. Said primers are capable of hybridizing with a complementary sequence. In the context of the invention, they are capable of hybridizing with the target sequence. The target sequence may be a nucleic acid sequence (DNA or RNA).
[0030] For the purposes of the invention, amplification means the amplification of the target sequence during a PCR reaction and therefore the increase in the number of copies of the target sequence. The primers hybridize with the previously denatured complementary sequence, followed by elongation of the strands by the action of the polymerase. The reaction continues with several successive cycles making it possible to increase the number of copies of the amplicon.
[0031] For the purposes of the invention, the term amplicon means a nucleic acid fragment corresponding to the sequence amplified during the PCR and delimited by the two primers used. The amplicon is therefore a copy of the target sequence.
[0032] For the purposes of the invention, the term “hybrid primer” means a primer comprising a nucleic acid sequence capable of hybridizing with a complementary strand of the target sequence and, at the 5' end, a nucleic acid sequence corresponding to the sequence of a primer belonging to another primer pair. In the context of the invention, the primer pair 2, 3 and 4 consists of hybrid primers. For example, the 1st oligonucleotide of the primer pair 2 comprises a sequence capable of hybridizing with a specific nucleic acid sequence (target B) and, at the 5' end, a nucleic acid sequence corresponding to the sequence of the 1st oligonucleotide of the primer pair 1 capable of hybridizing with another specific nucleic acid sequence (target A).
[0033] For the purposes of the invention, the term “concentration ratio” means the concentration ratio of primer pair 1 relative to a 2nd primer pair such as primer pair 2. For example, a ratio of 1:1 corresponds to an identical concentration of the 1st pair and the 2nd pair and a ratio of 10:1 corresponds to a 10 times higher concentration of the 1st couple compared to the 2nd. Detailed description of the invention
[0034] The subject of the invention is therefore a new method which aims to implement a so-called multiplex PCR without significantly increasing the number of different primers present in the reaction mixture. Multiplex PCRs are known which make it possible to identify a very large number of target sequences. Such PCRs require the presence of a high concentration of a pair of primers for a target sequence, multiplied by the number of target sequences. From at least 4.5 different pairs of primers, the reaction conditions are very complex. In addition, the appearance of a competition phenomenon between the primers results in an inhibition of the primers and aspecific amplifications and consequently results in very poor detection sensitivity.
[0035] Furthermore, sequencing is a quantitative molecular biology technology, that is to say, one that will preserve the proportionality of the nucleic acids that it sequences. Thanks to the invention, it is possible to amplify the nucleic acids by favoring certain ones. In particular, the nucleic acids of target A, compared to the others. These nucleic acids will thus be present in greater quantity and will therefore be sequenced more quickly. In diagnosis, favoring certain nucleic acids is linked to the fact that these nucleic acids are more informative than the others. Thanks to the invention, they will be analyzed as a priority and will allow a faster diagnosis.
[0036] Thus, the invention relates to a method for amplifying at least two distinct nucleic acid sequences present in a sample from a pair of primers 1 capable of amplifying a 1st nucleic acid sequence (A) and a pair of primers 2 capable of amplifying a 2nd nucleic acid sequence (B), said method comprising the following steps: a. bringing the sample into contact with the primer pair 1 capable of amplifying the nucleic acid sequence (A) and the primer pair 2 capable of amplifying the 2nd nucleic acid sequence (B), i. the primer pair 1 consisting of a 1st primer and a 2nd primer capable of amplifying a nucleic acid corresponding to the 1st sequence (A), ii. the primer pair 2 consisting of a 1st primer and a 2nd primer capable of amplifying a nucleic acid corresponding to the 2nd sequence (B), b. the addition of selected reagents and conditions enabling PCR amplification, and c. amplification of the 1st and 2nd nucleic acid sequences (A and B), in carrying out a specific amplification reaction of the nucleic acid sequence (A) and the nucleic acid sequence (B) present in the sample, characterized in that the sequence of the 1st primer of primer pair 2 further comprises in 5' the sequence of the 1st primer of primer pair 1 and the sequence of the 2nd primer of primer pair 2 further comprises in 5' the sequence of the 2nd primer of primer pair 1.
[0037] During a Duplex-Relay PCR, the PCR reaction takes place in a mixture comprising a pair of primers 1 capable of hybridizing and amplifying a 1st nucleic acid sequence (A) and a pair of primers 2 capable of hybridizing and amplifying a 2nd nucleic acid sequence (B) as is the case for a standard Duplex PCR. However, Duplex-Relay PCR differs from standard Duplex PCR in that it uses hybrid primers for the 2nd pair of primers.
[0038] The Duplex-Relay PCR notably comprises bringing the sample into contact with the reaction mixture comprising the primer pair 1 capable of amplifying the nucleic acid sequence (A) and the primer pair 2 capable of amplifying the 2nd nucleic acid sequence (B).
[0039] The primer pair 1 consists of a 1st primer and a 2nd primer each capable of hybridizing to the complementary sequence of one of the strands of the nucleic acid (A) and of amplifying the sequence corresponding to the sequence of the complementary strand between the two primers. Said complementary sequence being the target sequence (A).
[0040] The primer pair 2 consists of a 1st primer and a 2nd primer each capable of hybridizing to the complementary sequence of one of the strands of the nucleic acid (B) and of amplifying the sequence corresponding to the sequence of the complementary strand between the two primers. Said complementary sequence being the target sequence (B).
[0041] In addition, the reaction mixture comprises all the reagents and conditions necessary to carry out a PCR amplification. Said reagents may be initially present in the reaction mixture or added after contacting the sample. The necessary reagents include in particular dNTPs and the polymerase that a person skilled in the art will be able to choose depending on the PCR and the reaction conditions. Preferably, the polymerase is the polymerase of Thermophilus aquaticus or the so-called Klenow fragment of this polymerase.
[0042] Once all the constituents are present in the reaction mixture, amplification can begin.
[0043] The various stages of a PCR reaction are known to those skilled in the art. A PCR cycle includes a denaturation step which aims to separate the double strand in order to obtain two single strands followed by the hybridization step. During this step, the primers will recognize the complementary sequence present on one of the previously denatured single strands and will then hybridize. This is followed by an elongation step which allows the polymerases to synthesize the complementary strand of the single strand. This strand is synthesized from the free dNTPs present in the reaction medium. The duration of this step depends on the length of the sequence to be amplified.
[0044] The PCR reaction continues with a 2nd cycle, 3rd etc. which each include the same steps. At the end of the PCR, an amplification of the sequence between the primers is thus obtained. Said sequence corresponds to the amplicon.
[0045] Thus, the amplification of the 1st and 2nd nucleic acid sequence is specific to the target nucleic acid sequence (A) and the target nucleic acid sequence (B) present in the sample.
[0046] The method according to the invention is characterized in that the 1st primer of primer pair 2 further comprises in 5' the sequence of the 1st primer of primer pair 1, and the 2nd primer of primer pair 2 further comprises in 5' the sequence of the 2nd primer of primer pair 1.
[0047] Preferably, the 1st primer of primer pair 2 comprises a nucleic acid sequence capable of hybridizing with the complementary sequence of the sequence to be amplified, such as the target sequence (B) and furthermore in 5' the sequence of the 1st primer of primer pair 1, and the 2nd primer of primer pair 2 comprises a nucleic acid sequence capable of hybridizing with the complementary sequence of the sequence to be amplified, such as the target sequence (B) and furthermore in 5' the sequence of the 2nd primer of primer pair 1. The nucleic acid sequence capable of hybridizing with the complementary sequence to be amplified, such as the target sequence (B) being distinct for primer 1 and primer 2. In particular primer 1 may be a sense primer and primer 2 an antisense primer.
[0048] Preferably, the 1st pair of primers is capable of amplifying the 1st sequence (A) and the 2nd sequence (B) from the 2nd PCR cycle. Indeed, during the 1st PCR cycle, the 1st pair of primers is capable of amplifying the 1st sequence (A) and the 2nd pair of primers is capable of amplifying the 2nd sequence (B). At the end of the 1st PCR cycle, nucleic acid sequences are generated comprising the sequence of the 1st primer of the 1st pair and the sequence complementary to sequence (A), nucleic acid sequences comprising the sequence of the 2nd primer of the 1st pair and the sequence complementary to sequence (A), nucleic acid sequences comprising the sequence of the 1st primer of the 2nd pair and the sequence complementary to sequence (B), and nucleic acid sequences comprising the sequence of the 2nd primer of the 2nd pair and the sequence complementary to sequence (B).
[0049] Now, the 1st primer of the 2nd pair includes the sequence of the 1st primer of the 1st pair and a sequence capable of hybridizing to the sequence (B) and the 2nd primer of the 2nd pair comprises the sequence of the 2nd primer of the 1st pair and a sequence capable of hybridizing to the sequence (B). Thus, during the 2nd cycle, the primer pair 1 is capable of amplifying the nucleic acid sequences generated during the 1st cycle.
[0050] According to one embodiment, the sequence of the 1st primer of the 1st pair is chosen from SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5, the sequence of the 2nd primer of the 1st pair is chosen from SEQ ID NO: 2, SEQ ID NO: 4 or SEQ ID NO: 6, the sequence of the 1st primer of the 2nd pair is chosen from SEQ ID NO: 7 or SEQ ID NO: 9, the sequence of the 2nd primer of the 2nd pair is chosen from SEQ ID NO: 8 or SEQ ID NO: 10. Said sequences are listed in Table 1 below.
[0051] [Tables 1] 1st primer pair CGGAAGCAACGCGTAAACTC SEQ ID NO: 1 2nd primer TGAGCGTCGCAGAACATTACA SEQ ID NO: 2 1st primer pair TCGAAATTAAATGTTGTCGTGTCTT C SEQ ID NO: 3 2nd primer CAATATTTTCATTTTTGACATGGAG AGAAACATC SEQ ID NO: 4 1st primer pair GACGGGATATCTGACCAGTCGG SEQ ID NO: 5 2nd primer CCGGGTTTTGCGTAATGATCTG SEQ ID NO: 6 2nd primer pair TCGAAATTAAATGTTGTCGTGTCTT CCGGAAGCAACGCGTAAACTC SEQ ID NO: 7 2nd primer CAATATTTTCATTTTTGACATGGAG AGAAACATCTGAGCGTCGCAGAAC ATTACA SEQ ID NO: 8 2nd primer pair GACGGGATATCTGACCAGTCGGTC GAAATTAAATGTTGTCGTGTCTTC SEQ ID NO:9 2nd primer CCGGGTTTTGCGTAATGATCTGCA ATATTTTCATTTTTGACATGGAGA GAAACATC SEQ ID NO:10
[0052] During the method according to the invention, the concentration of primer pair 2 may be lower, higher or equal to that of primer pair 1. It is thus possible to favor or not one primer pair over another and therefore the amplification of a sequence of interest.
[0053] According to a particularly preferred embodiment of the invention, the concentration of primer pair 2 is less than or equal to that of primer pair 1. When the concentration of primer pair 2 is lower than that of primer pair 1, primer pair 2 is disadvantaged compared to the first pair. The amplicons generated by primer pair 1 will therefore be present in greater quantity. When sequencing is then carried out, the amplicons of target A will be over-represented and will therefore be preferentially sequenced. Obtaining their sequence will then be faster.
[0054] The method according to the invention makes it possible to generate a quantity of amplicons by primer pair 1 at least 4 times greater than the amplicons generated by primer pair 2. The amplicons generated by the 2nd pair will therefore be present in smaller quantities and will come out less quickly during sequencing.
[0055] Preferably, the concentration ratio between the primer pair 1 and the primer pair 2 is between 1:1 and 1000:1, even more preferably between 1:1 and 100:1. According to a particularly advantageous embodiment, the concentration ratio between the primer pair 1 and the primer pair 2 is equal to 10:1. Such a ratio may for example correspond to a concentration of the primer pair 1 equal to 1 mM and a concentration of the primer pair 2 equal to 0.1 mM.
[0056] According to another embodiment, the method according to the invention may further comprise bringing the sample into contact with a 3rd primer pair capable of amplifying a 3rd nucleic acid sequence (C). The 1st primer of primer pair 3 comprises a nucleic acid sequence capable of hybridizing with the complementary sequence (C) and furthermore in 5' the sequence corresponding to the sequence of the 1st primer of primer pair 1. The 2nd primer of primer pair 3 comprises a nucleic acid sequence capable of hybridizing with the complementary sequence (C) and furthermore in 5' the sequence corresponding to the sequence of the 2nd primer of primer pair 1.
[0057] The method according to the invention thus comprises 3 different pairs of primers making it possible to amplify 3 different target nucleic acid sequences, in particular a sequence A, a sequence B and a sequence C. Said method is a so-called Triplex-Relay PCR.
[0058] During the process, the concentration of primer pair 3 is less than or greater than or equal to that of primer pair 1 and / or the concentration of primer pair 2 is less than or greater than or equal to that of primer pair 1. It is thus possible to favor or not one primer pair over another.
[0059] Preferably, the concentration of primer pair 1 is greater than that of the 2nd and 3rd primer pairs and the concentration of primer pair 2 is equal to that of primer pair 3.
[0060] According to one embodiment, the concentration of the primer pair 1 is greater than that of the 2nd and 3rd primer pair and the concentration of primer pair 2 is higher than that of primer pair 3. Thus, the 1st pair is favored over the 2nd and the 2nd is also favored over the 3rd.
[0061] According to another embodiment, the method according to the invention may further comprise bringing the sample into contact with a 4th primer pair capable of amplifying a 4th nucleic acid sequence (D). The 1st primer of primer pair 4 comprises a nucleic acid sequence capable of hybridizing with the complementary sequence (D) and furthermore in 5' the sequence corresponding to the sequence of the 1st primer of primer pair 1. The 2nd primer of primer pair 4 comprises a nucleic acid sequence capable of hybridizing with the complementary sequence (D) and furthermore in 5' the sequence corresponding to the sequence of the 2nd primer of primer pair 1.
[0062] Preferably, the concentration of the 4th pair of primers is less than or equal to the concentration of the pair of primers 1 and the concentration of the 2nd, 3rd and 4th pair is identical.
[0063] According to another embodiment, the method according to the invention may further comprise bringing the sample into contact with an nth pair of primers capable of amplifying an nth nucleic acid sequence. The 1st primer of the primer pair n comprises a nucleic acid sequence capable of hybridizing with the target complementary sequence and furthermore in 5' the sequence corresponding to the sequence of the 1st primer of the primer pair 1. The 2nd primer of the primer pair n comprises a nucleic acid sequence capable of hybridizing with the target complementary sequence and furthermore in 5' the sequence corresponding to the sequence of the 2nd primer of the primer pair 1.
[0064] Preferably, the concentration of the nth pair of primers is less than or equal to the concentration of the pair of primers 1 and the concentration of the 2nd, 3rd, 4th pair and nth pair is identical.
[0065] For the purposes of the invention, the term "n" means a natural integer which is a positive number making it possible to count objects each counting as one. Thus, an integer has a unique successor, that is to say an integer which is immediately greater than it, and the list of natural integers is infinite.
[0066] Furthermore, the reaction medium for implementing the method according to the invention may comprise one or more specific probe(s) coupled to a fluorophore whose emission spectrum is different from the others. Thus, each product of the PCR reaction is measured in real time by said specific probe(s).
[0067] Thus, according to one embodiment, the method according to the invention further comprises a step of quantifying the amplicons by the use of probes coupled to a fluorophore, preferably so-called TaqMan probes.
[0068] Such probes according to the invention are listed in Table 2 below.
[0069] [Tables2] Probe 1 (EC) CGCGTCCGATCACCTGCGT C SEQ ID NO: 11 Probe 2 (KP) GTTGAGGTCAACAGTGCT GCGG SEQ ID NO: 12 Probe 3 (SA) TCGCGACATTCATTATGCC CA SEQ ID NO: 13
[0070] According to another embodiment, the method according to the invention comprises a step of detecting the amplicons by fluorescent probes, fluorescent labeling, melting curve, nested PCR or by DNA sequencing.
[0071] When the detection of the amplicons is done by sequencing, the method further comprises a step of sequencing the amplified nucleic acids or amplicons.
[0072] According to a particularly preferred embodiment, the method according to the invention makes it possible to detect and identify microorganisms (bacteria, yeasts, viruses, etc.) involved in infectious diseases, preferably bacteria.
[0073] The method according to the invention can also be used for the diagnosis of genetic diseases, in oncology and generally in molecular biology.
[0074] According to another aspect, the invention relates to a kit comprising a pair of primers 1 comprising SEQ ID No. 1 and SEQ ID No. 2 or SEQ ID No. 3 and SEQ ID No. 4 or SEQ ID No. 5 and SEQ ID No. 6 and a pair of primers 2 comprising SEQ ID No. 7 and SEQ ID No. 8 or SEQ ID No. 9 and SEQ ID No. 10.
[0075] Preferably, the kit according to the invention is capable of implementing the method according to the invention.
[0076] The invention also relates to the use of the kit according to the invention for detecting microorganisms present during infectious diseases, such as bacteria, viruses or yeasts. Preferably, the invention relates to the use of the kit for diagnosing an infectious disease.
[0077] The invention also relates to the use of the kit according to the invention for detecting at least one genetic disease or at least one cancer. Examples
[0078] Materials and method
[0079] Relay PCR reactions were performed as follows: 0.2mM dNTP, 4mM MgCl2, 0.05 units of FastStart polymerase (Roche) and buffer according to the supplier's conditions. The TaqMan probes for primer pair 1 were at 0.25mM while those for primer pair 2 were at 0.1mM. The primer pairs were put at different concentrations: ImM for standard Duplexes, ImM for primer pair 1 in Duplex-Relays and 0.1mM or ImM for primer pair 2 in Duplex-Relays. The cycling was as follows: denaturation at 95°C for 10 min then 55 cycles at 95°C for 15 sec / 55°C for 15 sec / 68°C for 15 sec. Approximately 100 equivalent genome copies of each of the bacteria tested were added to the mixes to carry out the amplifications.
[0080] Results
[0081] Example 1 of the method according to the invention for the amplification of two sequences of a specific gene for Staphyloccocus aureus and Escherichia coli.
[0082] The amplification of the two sequences of interest was carried out by a standard duplex PCR, by Relay PCR according to the invention with a primer pair ratio Lprimer pair 2 equal to 10:1 and by Relay PCR according to the invention with a primer pair ratio Lprimer pair 2 equal to 1:1.
[0083] In the context of the standard Duplex PCR, the two pairs of primers were put in high concentration. The pair of primers for amplifying the specific sequence of the Staphyloccocus aureus gene consists of the primers with sequences SEQ ID NO: 3 and SEQ ID NO: 4 and the pair for amplifying Escherichia coli consists of the primers with sequences SEQ ID NO: 1 and SEQ ID NO: 2. The results are shown in [fig. 2A] and Table 3. The inventors thus observed a superposition of the Cq (number of cycles initiating a detection of the fluorescence signal) meaning that an identical quantity of bacterial genome was indeed added to the PCR mix. In addition, the same quantity of Escherichia coli and Staphyloccocus aureus amplicons were generated.
[0084] During the Duplex-Relay PCR with a 10:1 ratio, primer pair 1 consists of primers with sequences SEQ ID NO:2 and SEQ ID NO:3 and primer pair 2 consists of primers with sequences SEQ ID NO:7 and SEQ ID NO:8. The 1st primer pair makes it possible to amplify the specific sequence of the Staphyloccocus aureus gene and the 2nd hybrid primer pair makes it possible to amplify the specific sequence of the Escherichia coli gene. The results are shown in [fig.2B] and Table 3. The inventors thus observed a shift in Cq of the curves between the Staphyloccocus aureus and Escherichia coli amplifications. This delay caused by the Duplex-Relay PCR was 2.09 cycles (35.27-33.18) for a primer ratio of 10:1, i.e., approximately a factor of 4 (2A1.99). It leads to a quantity differential of approximately 4 times fewer amplicons relating to the Escherichia coli gene compared to the Staphyloccocus aureus amplicons.
[0085] In the Relay PCR with a 1:1 ratio, the primer pairs used are identical to those used in the Relay PCR (10:1 ratio). The results are shown in [fig.2C] and Table 3. The inventors also observed a shift of Cq of the curves between Staphyloccocus aureus and Escherichia coli amplifications. This delay caused by the Duplex-Relay PCR was 1.79 cycles (35.68-33.89), or approximately a factor of 3.5 (2A1.79). The differential quantity of amplicons was again observed for similar factors.
[0086] [Tables3] Cq SA M. Cq SA SD. Cq SA Cq EC M. EC SD. EC PCR Duplex 32.61 32.95 0.31 32.99 32.90 0.11 33.04 32.93 33.2 32.78 PCR Relay 10:1 33.06 33.18 0.20 35.37 35.27 0.10 33.41 35.28 33.08 35.17 PCR Relay 1:1 34.42 33.89 0.51 35.77 35.68 0.08 33.85 35.62 33.4 35.65
[0087] M. Cq = average of the Cq.
[0088] SD. Cq= standard deviation of Cq.
[0089] SA: values for Staphyloccocus aureus
[0090] EC: values for Escherichia coli.
[0091] Example 2 of the method according to the invention for the amplification of two sequences of a gene specific to Klebsiella pneumoniae and Staphyloccocus aureus.
[0092] The amplification of the two sequences of interest was carried out by a standard Duplex PCR, and by Duplex-Relay PCR according to the invention with a primer pair 1: primer pair 2 ratio equal to 10:1 and by Duplex-Relay PCR according to the invention with a primer pair 1: primer pair 2 ratio equal to 1:1.
[0093] In the context of the standard Duplex PCR, the two pairs of primers were put in high concentration. The pair of primers allowing to amplify the specific sequence of the Klebsiella pneumoniae gene is made up of the primers of sequence SEQ ID NO: 5 and SEQ ID NO: 6 and the pair allowing to amplify Staphylococcus aureus is made up of the primers of sequences SEQ ID NO: 3 and SEQ ID NO: 4. The results are represented in [fig. 3A] and Table 4. The inventors thus observed a superposition of the Cq (number of cycles initiating a detection of the fluorescence signal) signifying that an identical quantity of bacterial genome was indeed added to the PCR mix. In addition, as much quantity of Klebsiella pneumoniae and Staphy- loccocus aureus were generated.
[0094] During the Relay PCR with a 10:1 ratio, primer pair 1 consists of primers with sequences SEQ ID NO: 5 and SEQ ID NO: 6 and primer pair 2 consists of primers with sequences SEQ ID NO: 9 and SEQ ID NO: 10. The first primer pair makes it possible to amplify the specific sequence of the Klebsiella pneumoniae gene and the second hybrid primer pair makes it possible to amplify the specific sequence of the Staphyloccocus aureus gene. The results are shown in [fig. 3B] and Table 4. The inventors thus observed a shift in Cq of the curves between the Klebsiella pneumoniae and Staphyloccocus aureus amplifications. The delay caused by the Duplex-Relay PCR was 1.99 cycles (35.35-33.36) for the 10:1 primer ratio, i.e., approximately a factor of 4 (2A1.99). This leads to a quantity differential of approximately 4 times fewer amplicons related to the Staphyloccocus aureus gene compared to the Klebsiella pneumoniae amplicons.
[0095] During the Relay PCR with a 1:1 ratio, the primer pairs used are identical to those used in the Relay PCR (ratio 10:1). The results are presented in [fig.3C] and Table 4. The inventors also observed a shift in Cq of the curves between the Klebsiella pneumoniae and Staphyloccocus aureus amplifications. The delay caused by the Duplex-Relay PCR was 2.59 cycles (36.43-33.84), or approximately a factor of 6 (2A2.59). It leads to a quantity differential of approximately 6 times fewer amplicons relating to the Staphyloccocus aureus gene compared to the Klebsiella pneumoniae amplicons.
[0096] [Tables4] Cq KP M. Cq KP SD. Cq KP Cq SA M. SA SD. SA PCR Duplex 33.9 33.85 0.10 33.51 33.44 0.08 33.91 33.47 33.73 33.35 PCR Relay 10:1 33.5 33.36 0.15 35.09 35.35 0.27 33.37 35.63 33.2 35.32 PCR Relay 1:1 33.31 33.84 0.51 36.27 36.43 0.15 33.89 36.45 34.33 36.56
[0097] M. Cq = average of the Cq.
[0098] SD. Cq= standard deviation of Cq.
[0099] KP: values for Klebsiella pneumoniae
[0100] SA: values for Staphyloccocus aureus
Claims
Claims
1. Method for amplifying at least two distinct nucleic acid sequences of interest present in a sample from a primer pair 1 capable of amplifying a 1st nucleic acid sequence of interest (A) and a primer pair 2 capable of amplifying a 2nd nucleic acid sequence of interest (B), said method comprising the following steps: a. bringing the sample into contact with the primer pair 1 capable of amplifying the nucleic acid sequence (A) and the primer pair 2 capable of amplifying the 2nd nucleic acid sequence (B), i. the primer pair 1 consisting of a 1st primer and a 2nd primer capable of amplifying a nucleic acid corresponding to the 1st sequence (A), ii. the primer pair 2 consisting of a 1st primer and a 2nd primer capable of amplifying a nucleic acid corresponding to the 2nd sequence (B), b. the addition of selected reagents and conditions allowing PCR amplification, and c.the amplification of the 1st and 2nd nucleic acid sequences, by carrying out a specific amplification reaction of the nucleic acid sequence (A) and the nucleic acid sequence (B) present in the sample, characterized in that the sequence of the 1st primer of primer pair 2 further comprises in 5' the sequence of the 1st primer of primer pair 1 and the sequence of the 2nd primer of primer pair 2 further comprises in 5' the sequence of the 2nd primer of primer pair 1.
2. Method according to the preceding claim, characterized in that the concentration of the primer pair 2 is less than or equal to that of the primer pair 1.
3. Method according to the preceding claim, characterized in that the concentration ratio between the primer pair 1 and the primer pair 2 is between 1:1 and 1000:
1.
4. Method according to the preceding claim, characterized in that the concentration ratio between the primer pair 1 and the primer pair 2 is between 1:1 and 100:1, preferably 10:
1.
5. Method according to one of the preceding claims, comprising in in addition to bringing the sample into contact with a pair of primers 3 capable of amplifying a nucleic acid corresponding to the 3rd nucleic acid sequence (C), characterized in that the sequence of the 1st primer of the pair of primers 3 further comprises in 5' the sequence of the 1st primer of the pair of primers 1 and the sequence of the 2nd primer of the pair of primers 3 further comprises in 5' the sequence of the 2nd primer of the pair of primers 1.
6. Method according to the preceding claim, in which the concentration of the primer pair 3 is less than or equal to the concentration of the primer pair 1.
7. Method according to one of the preceding claims, in which the sequences of interest correspond to conserved sequences of a single gene or of at least two distinct genes.
8. Method according to the preceding claim, in which the concentration of the primer pair 1 is greater than or equal to the concentration of the 2nd and / or 3rd pair.
9. Method according to the preceding claim, in which the concentration of the primer pair 2 is equal to that of the primer pair 3.
10. Method according to one of claims 7 to 9, further comprising bringing the sample into contact with a pair of primers 4 capable of amplifying a 4th nucleic acid sequence (D), characterized in that the sequence of the 1st primer of the pair of primers 4 further comprises in 5' the sequence of the 1st primer of the pair of primers 1 and the sequence of the 2nd primer of the pair of primers 4 further comprises in 5' the sequence of the 2nd primer of the pair of primers 1.
11. Method according to the preceding claim, in which the concentration of the primer pair 4 is less than or equal to the concentration of the primer pair 1.
12. Method according to the preceding claim, in which the concentration of primer pair 2, primer pair 3 and primer pair 4 is identical.
13. A method according to any preceding claim, wherein the PCR is a multiplex PCR.
14. Method according to one of the preceding claims, further comprising a step of sequencing the amplified nucleic acids.
15. Method according to one of the preceding claims, in which the amplification of the nucleic acid sequences of interest makes it possible to detect and identify at least one microorganism involved in at least one of the preceding claims. less an infectious disease.
16. Method according to the preceding claim, characterized in that the bacteria are identified by fluorescent probes, fluorescent labeling, melting curve, nested PCR or by DNA sequencing.
17. Kit comprising a pair of primers 1 comprising SEQ ID NO: 1 and SEQ ID NO: 2 and a pair of primers 2 comprising SEQ ID NO: 3 and SEQ ID NO:
4.
18. Use of a kit according to the preceding claim for implementing the method according to one of claims 1 to 16 and detecting at least one microorganism present during at least one infectious disease.
19. Use of a kit according to claim 17 for detecting at least one genetic disease or at least one cancer.
